3,4-Methylenedioxyphenyl ethyl ketone

Suppliers

Names

[ CAS No. ]:
28281-49-4

[ Name ]:
3,4-Methylenedioxyphenyl ethyl ketone

[Synonym ]:
3′,4′-(Methylenedioxy)propiophenone
3',4'-Methylenedioxypropiophenone
5-propionyl-1,3-benzodioxole
1-(Benzo[d][1,3]dioxol-5-yl)propan-1-one
MFCD00016652
EINECS 248-937-6

Chemical & Physical Properties

[ Density]:
1,21 g/cm3

[ Boiling Point ]:
165-168°C 20mm

[ Melting Point ]:
34-36°C

[ Molecular Formula ]:
C10H10O3

[ Molecular Weight ]:
178.18500

[ Flash Point ]:
165-168°C/20mm

[ Exact Mass ]:
178.06300

[ PSA ]:
35.53000

[ LogP ]:
2.00800

[ Vapour Pressure ]:
0.000771mmHg at 25°C

[ Index of Refraction ]:
1.546

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UC0440600
CHEMICAL NAME :
1-Propanone, 1-(1,3-benzodioxol-5-yl)-
CAS REGISTRY NUMBER :
28281-49-4
LAST UPDATED :
199706
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C10-H10-O3
MOLECULAR WEIGHT :
178.20

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- Volume(issue)/page/year: 21,341,1987

Safety Information

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R33

[ Safety Phrases ]:
S26-S37

[ RTECS ]:
UC0440600

[ HS Code ]:
2932999099

Synthetic Route

Customs

[ HS Code ]: 2932999099

[ Summary ]:
2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • N-[2-(3,4-methylenedioxyphenyl)ethyl](3,4-dimethoxy-2-hydroxymethyl)-phenylacetamide
  • N-(2-(3,4-methylenedioxyphenyl)ethyl)(3,4-methylenedioxy-2-hydroxymethyl)-phenylacetamide
  • 1-[2-(3,4-Methylenedioxyphenyl)ethyl]-4-phenyl-2,2,6-trimethylpiperazine
  • (6R)-7-[2-(3,4-methylenedioxyphenyl)ethyl]-1,4-dioxa-7-azadispiro[4.0.4.3]tridecan-8-one
  • (5R)-1-[2-(3,4-methylenedioxyphenyl)ethyl]-1-azaspiro[4.4]nonane-2,6-dione
  • (5S)-1-[2-(3,4-methylenedioxyphenyl)ethyl]-1-azaspiro[4.4]non-7-ene-2,6-dione
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • N-(2-methylpropyl)-2-(pyridin-4-yl)quinoline-4-carboxamide
  • 7-[2-(4-benzylpiperazin-1-yl)ethoxy]-3-(4-methoxyphenyl)-2-methyl-4H-chromen-4-one
  • 1-(1-acetylpiperidin-4-yl)-1H-1,2,3-triazole-4-carbaldehyde
  • 2-Cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 3-Fluoro-N-(3-methoxypropyl)-5-(1,4-dioxa-8-azaspiro[4.5]decan-8-YL)benzenesulfonamide
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol